• Bristol Myers Squibb EPS for the quarter ending March 31, 2025 was $1.20, a 120.37% decline year-over-year.
• Bristol Myers Squibb 2024 annual EPS was $-4.41, a 214.25% decline from 2023.
• Bristol Myers Squibb 2023 annual EPS was $3.86, a 30.85% increase from 2022.
• Bristol Myers Squibb 2022 annual EPS was $2.95, a 5.45% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.